Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors.
COVID-19
SARS-CoV-2
antibodies
serological test
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
27 Aug 2020
27 Aug 2020
Historique:
received:
29
06
2020
revised:
08
08
2020
accepted:
18
08
2020
entrez:
2
9
2020
pubmed:
2
9
2020
medline:
2
9
2020
Statut:
epublish
Résumé
We aimed to assess the prevalence of and factors associated with anti- severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) positivity in a large population of adult volunteers from five administrative departments of the Liguria and Lombardia regions. A total of 3609 individuals were included in this analysis. Participants were tested for anti-SARS-CoV-2 antibodies [Immunoglobulin G (IgG) and M (IgM) class antibodies] at three private laboratories (Istituto Diganostico Varelli, Medical Center, and Casa della Salute di Genova). Demographic data, occupational or private exposure to SARS-CoV-2-infected patients, and prior medical history consistent with SARS-CoV-2 infection were collected according to a preplanned analysis. The overall seroprevalence of anti-SARS-CoV-2 antibodies (IgG and/or IgM) was 11.0% [398/3609; confidence interval (CI) 10.0%-12.1%]. Seroprevalence was higher in female inmates than in male inmates (12.5% vs. 9.2%, respectively,
Identifiants
pubmed: 32867328
pii: jcm9092780
doi: 10.3390/jcm9092780
pmc: PMC7563864
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Microbiol Infect. 2020 Jul;26(7):948.e1-948.e3
pubmed: 32360780
Emerg Infect Dis. 2020 Nov;26(11):2761-2763
pubmed: 32726200
Clin Chem Lab Med. 2020 Jun 25;58(7):1156-1159
pubmed: 32301750
Lancet. 2020 Aug 1;396(10247):313-319
pubmed: 32534626
Crit Rev Clin Lab Sci. 2020 Sep;57(6):400-414
pubmed: 32662342
J Clin Virol. 2003 Jul;27(2):170-9
pubmed: 12829039
Travel Med Infect Dis. 2020 May - Jun;35:101608
pubmed: 32114075
J Med Virol. 2020 May 8;:
pubmed: 32383174
BMJ. 2020 May 4;369:m1818
pubmed: 32366498
Clin Geriatr Med. 2016 Aug;32(3):585-607
pubmed: 27394025
J Med Virol. 2020 Feb 27;:
pubmed: 32104917
Diagnostics (Basel). 2020 Jul 04;10(7):
pubmed: 32635444
BMC Infect Dis. 2016 Nov 4;16(1):637
pubmed: 27814689
MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):965-970
pubmed: 32701941
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930
ACS Chem Neurosci. 2020 May 6;11(9):1200-1203
pubmed: 32283006
MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):960-964
pubmed: 32701938
JAMA. 2020 Jun 16;323(23):2425-2427
pubmed: 32421144
Eur J Clin Invest. 2020 Mar;50(3):e13209
pubmed: 32003000
J Am Med Dir Assoc. 2016 Jan;17(1):85-8
pubmed: 26712489
JAMA Intern Med. 2020 Jul 21;:
pubmed: 32692365
Clin Infect Dis. 2020 Jun 16;:
pubmed: 32544951
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
J Am Geriatr Soc. 2020 Aug;68(8):1653-1656
pubmed: 32484912
Euro Surveill. 2020 Jun;25(24):
pubmed: 32583766
Emerg Infect Dis. 2019 Feb;25(2):383-384
pubmed: 30666949
Euro Surveill. 2020 Jul;25(28):
pubmed: 32700672
Clin Chem Lab Med. 2020 Jun 25;58(7):1081-1088
pubmed: 32301749
J Am Geriatr Soc. 2020 May;68(5):942
pubmed: 32216132
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
J Am Med Dir Assoc. 2020 Jan;21(1):104-109.e1
pubmed: 31101588
Geriatr Nurs. 2015 Jul-Aug;36(4):267-72
pubmed: 25794923
Rev Saude Publica. 2020;54:69
pubmed: 32638883